Search - tctmd.com

Displaying 61 - 80 of 300

Sort: Relevancy | Date

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Use of DAPT Score Following PCI Validated in PRODIGY Study

Yael L. Maxwell

June 12, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Todd Neale

September 13, 2016

News Daily News

Gender Should Not Factor Into DAPT Choice After PCI

L.A. McKeown

August 19, 2016

News Daily News

药物涂层球囊最适合 BMS 而不是 DES 支架内再狭窄

Caitlin E. Cox

August 17, 2016

News Daily News

Los Balones Recubiertos de Fármacos son Más Aptos para el Manejo de la Reestenosis Intra-Stent en SMD que en SLF

Caitlin E. Cox

August 17, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

L.A. McKeown

June 29, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

Advertisement

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Use of DAPT Score Following PCI Validated in PRODIGY Study

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Gender Should Not Factor Into DAPT Choice After PCI

药物涂层球囊最适合 BMS 而不是 DES 支架内再狭窄

Los Balones Recubiertos de Fármacos son Más Aptos para el Manejo de la Reestenosis Intra-Stent en SMD que en SLF

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content